Candriam SCA
ONCE

Candriam SCA’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Candriam SCA’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-62,007
Closed -$6.32M – 832
2019
Q2 		$6.32M Buy
62,007
+3,007
+5% +$324K 0.08% 278
2019
Q1 		$6.72M Sell
59,000
-100
-0.2% -$7.35K 0.09% 262
2018
Q4 		$2.31M Hold
59,100
– – 0.04% 427
2018
Q3 		$3.22M Buy
59,100
+28,700
+94% +$1.96M 0.04% 408
2018
Q2 		$2.52M Buy
+30,400
New +$2.35M 0.04% 437
2017
Q4 		– Sell
-55,000
Closed -$4.9M – 787
2017
Q3 		$4.9M Buy
55,000
+28,000
+104% +$2.13M 0.09% 268
2017
Q2 		$1.61M Hold
27,000
– – 0.03% 501
2017
Q1 		$1.44M Sell
27,000
-9,000
-25% -$534K 0.03% 500
2016
Q4 		$1.8M Buy
36,000
+11,000
+44% +$589K 0.04% 391
2016
Q3 		$1.5M Sell
25,000
-29,000
-54% -$1.67M 0.04% 414
2016
Q2 		$2.76M Buy
54,000
+24,000
+80% +$1.03M 0.07% 262
2016
Q1 		$881K Sell
30,000
-10,000
-25% -$315K 0.02% 451
2015
Q4 		$1.81M Buy
+40,000
New +$2.1M 0.05% 313
2015
Q3 		– Sell
-60,000
Closed -$3.62M – 656
2015
Q2 		$3.62M Buy
60,000
+5,000
+9% +$331K 0.08% 284
2015
Q1 		$4.26M Buy
+55,000
New +$3.17M 0.09% 278

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Pentwater Capital Management
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Candriam SCA's ONCE Position: Q3 2019 in Review

Candriam SCA sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 62,007 shares — an estimated $6.32M sold.

Candriam SCA first reported a position in ONCE in Q1 2015 and held it in 15 quarters. The position peaked at $6.72M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Candriam SCA reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Candriam SCA sold 62,007 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $6.32M.
  • Candriam SCA first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 15 quarters.
  • Candriam SCA's Spark Therapeutics, Inc. Common Stock position peaked at $6.72M in Q1 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.